Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer

被引:29
|
作者
Komaki, R
Milas, L
Ro, JY
Fujii, T
Perkins, P
Allen, P
Sikes, CR
Mountain, CF
Ordonez, NG
机构
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Cancer Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Cancer Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1998年 / 40卷 / 04期
关键词
non-small-cell lung cancer; pathological N1; biomarkers; prognostic factors;
D O I
10.1016/S0360-3016(97)00898-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The prognostic influence of 6 biomarkers correlated to histologic subtypes of non-small cell lung cancer (NSCLC) on loco-regional control, overall survival, disease-free survival (DFS), and distant disease control (DDC) rates, all measured at 5 years, were examined. Materials & Methods: Cell blocks from the primary tumors of 137 patients with pathologically staged N1 NSCLC at MDACC were analyzed by 6-biomarker status correlated to histological subtypes and their outcomes. Results: The ranges of biomarker values were as follows: apoptotic index, 0.2-2.8%; mitotic index, 0-1.8%; the proportion of cells in S+G2M, 3-36%; p53 status, 0-100%; Ki-67, 0-9.3%; DNA index, 1.0-2.74. Subtypes of 137 cases from the postoperative pathology specimen showed that 74 patients had squamous carcinoma and 63 patients had adenocarcinoma. Mean and median lengths of follow-up were 4.21 years and 2.43 years, respectively. Patients with squamous cell carcinoma (SCC) had a better 5-year survival (p = 0.006), DFS (p = 0.002), and distant metastasis control (p = 0.002) than patients with adenocarcinoma (AC). Among'patients with AC, the DNA index was a significant predictor of 5-year DFS (p = 0.02), DDC rate (p = 0.04), and local-regional control (p < 0.05). Higher apoptosis (p = 0.03) and mitosis indices (p = 0.03) were also univariate predictors of increased distant disease among patients with AC. Multivariate analysis of patients with AC revealed that the DNA index and Ki-67 were the only significant independent predictors of distant metastasis (p < 0.04 and p < 0.02, respectively) and DFS (p < 0.04 for both). Among patients with SCC, univariate analysis showed that S+G2M proportion (p < 0.05) and Ki-67 levels (p < 0.02) were significant predictors for local-regional control; for SC, multivariate analysis showed that only mitosis was a significant predictor in this case for overall survival (p < 0.04). Conclusion: Spontaneous apoptotic index and Ki-67 were significantly higher in SC than in AC. Patients with SC had less distant metastasis better DFS and overall survival than those with AC. Multivariate analysis revealed that DNA index and Ki-67 status were significant predictors for DDC and DFS in patients with AC, but only mitotic index was a significant predictor of overall survival for patients with SCC. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:787 / 796
页数:10
相关论文
共 50 条
  • [21] Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer
    Wisnivesky, Juan P.
    Arciniega, Jacqueline
    Mhango, Grace
    Mandeli, John
    Halm, Ethan A.
    THORAX, 2011, 66 (04) : 287 - 293
  • [22] Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non-Small Cell Lung Cancer
    Demir, Adalet
    Turna, Akif
    Kocaturk, Celalettin
    Gunluoglu, Mehmet Zeki
    Aydogmus, Umit
    Urer, Nur
    Bedirhan, Mehmet Ali
    Gurses, Atilla
    Dincer, Seyit Ibrahim
    ANNALS OF THORACIC SURGERY, 2009, 87 (04): : 1014 - 1022
  • [23] Prognostic Impact of Lymph Node Ratio in Patients with Pathologic Stage N1 Non-Small Cell Lung Cancer
    Shin, Sumin
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Kwhanmien
    Kim, Jhingook
    Zo, Jae Ill
    Shim, Young Mog
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S337 - S337
  • [24] Survival and Prognostic Factor in Pathological N1 Non-Small-Cell Lung Cancer
    Yamamoto, Taketsugu
    Maehara, Takamitsu
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S670 - S670
  • [25] Phase I study of N1,N11-diethylnorspermine in patients with non-small cell lung cancer
    Hahm, HA
    Ettinger, DS
    Bowling, K
    Hoker, B
    Chen, TL
    Zabelina, Y
    Casero, RA
    CLINICAL CANCER RESEARCH, 2002, 8 (03) : 684 - 690
  • [26] Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung
    Riquet, M
    Manac'h, D
    Le Pimpec-Barthes, F
    Dujon, A
    Chehab, A
    ANNALS OF THORACIC SURGERY, 1999, 67 (06): : 1572 - 1576
  • [27] Mitochondrial Pyruvate Carrier 1 as a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer
    Zou, Hongbo
    Yin, Yunfei
    Xiong, Kai
    Luo, Xuelian
    Sun, Zhongju
    Mao, Bijing
    Xie, Qichao
    Tan, Mei
    Kong, Rui
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [28] Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study
    Decaluwe, Herbert
    Dooms, Christophe
    D'Journo, Xavier Benoit
    Call, Sergi
    Sanchez, David
    Haager, Benedikt
    Beelen, Roel
    Kara, Volkan
    Klikovits, Thomas
    Aigner, Clemens
    Tournoy, Kurt
    Zahin, Mahmood
    Moons, Johnny
    Brioude, Geoffrey
    Trujillo, Juan Carlos
    Klepetko, Walter
    Turna, Akif
    Passlick, Bernward
    Molins, Laureano
    Rami-Porta, Ramon
    Thomas, Pascal
    De Leyn, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (06)
  • [29] Approach to Resectable N1 Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database
    Pu, Chan Y.
    Rodwin, Sarah
    Nelson, Bre
    Fayyaz, Najya
    Scott, Nicholas
    Bouchard, Rene J.
    Groman, Adrienne
    Hennon, Mark
    Yendamuri, Sai
    JOURNAL OF SURGICAL RESEARCH, 2021, 259 : 145 - 153
  • [30] ARL14 as a Prognostic Biomarker in Non-Small Cell Lung Cancer
    Zhang, Binbin
    Xu, Aiqun
    Wu, Dong
    Xia, Wanli
    Li, Pulin
    Wang, Enze
    Han, Rui
    Sun, Peng
    Zhou, Sijing
    Wang, Ran
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 6557 - 6574